nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—Composition of Lipid Particles—APOE—pancreatic cancer	0.0807	0.0807	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.0492	0.0492	CbGpPWpGaD
Tyloxapol—LPL—Chylomicron-mediated lipid transport—APOE—pancreatic cancer	0.0485	0.0485	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.048	0.048	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—APOE—pancreatic cancer	0.0316	0.0316	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—APOE—pancreatic cancer	0.0308	0.0308	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—APOE—pancreatic cancer	0.024	0.024	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—AHR—pancreatic cancer	0.0214	0.0214	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—APOE—pancreatic cancer	0.0205	0.0205	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.0182	0.0182	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—GADD45A—pancreatic cancer	0.0159	0.0159	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	0.015	0.015	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—APOE—pancreatic cancer	0.0142	0.0142	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PPARG—pancreatic cancer	0.0138	0.0138	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARG—pancreatic cancer	0.0126	0.0126	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOE—pancreatic cancer	0.0122	0.0122	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	0.0121	0.0121	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	0.0118	0.0118	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ACVR1B—pancreatic cancer	0.0118	0.0118	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NR5A2—pancreatic cancer	0.0118	0.0118	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	0.0117	0.0117	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	0.0109	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PDX1—pancreatic cancer	0.0106	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	0.0106	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	0.0101	0.0101	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	0.01	0.01	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—HIF1A—pancreatic cancer	0.00976	0.00976	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP3—pancreatic cancer	0.00902	0.00902	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRP1—pancreatic cancer	0.00867	0.00867	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	0.00853	0.00853	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARG—pancreatic cancer	0.0083	0.0083	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—RB1—pancreatic cancer	0.00794	0.00794	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TGFB1—pancreatic cancer	0.00717	0.00717	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SLC2A2—pancreatic cancer	0.0067	0.0067	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—pancreatic cancer	0.0067	0.0067	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—pancreatic cancer	0.00667	0.00667	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—pancreatic cancer	0.00656	0.00656	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GDI2—pancreatic cancer	0.00645	0.00645	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GDI1—pancreatic cancer	0.00645	0.00645	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IAPP—pancreatic cancer	0.00636	0.00636	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CTNNB1—pancreatic cancer	0.00584	0.00584	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—pancreatic cancer	0.00579	0.00579	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRSS1—pancreatic cancer	0.00558	0.00558	CbGpPWpGaD
Tyloxapol—LPL—Disease—ZNRF3—pancreatic cancer	0.00558	0.00558	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—pancreatic cancer	0.00545	0.00545	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—pancreatic cancer	0.00509	0.00509	CbGpPWpGaD
Tyloxapol—LPL—Disease—DTX1—pancreatic cancer	0.00505	0.00505	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TGFB1—pancreatic cancer	0.00472	0.00472	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRSS1—pancreatic cancer	0.00468	0.00468	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—pancreatic cancer	0.00441	0.00441	CbGpPWpGaD
Tyloxapol—LPL—Disease—DTX4—pancreatic cancer	0.00423	0.00423	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRLHR—pancreatic cancer	0.00416	0.00416	CbGpPWpGaD
Tyloxapol—LPL—Disease—PPP2R5B—pancreatic cancer	0.00412	0.00412	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SMAD4—pancreatic cancer	0.0041	0.0041	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ARG2—pancreatic cancer	0.00405	0.00405	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HES1—pancreatic cancer	0.004	0.004	CbGpPWpGaD
Tyloxapol—LPL—Disease—HEY2—pancreatic cancer	0.00396	0.00396	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ZNRF3—pancreatic cancer	0.00391	0.00391	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ACVR1B—pancreatic cancer	0.00391	0.00391	CbGpPWpGaD
Tyloxapol—LPL—Disease—HEY1—pancreatic cancer	0.00367	0.00367	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMP—pancreatic cancer	0.00354	0.00354	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DTX1—pancreatic cancer	0.00354	0.00354	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SSTR3—pancreatic cancer	0.00354	0.00354	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SSTR1—pancreatic cancer	0.00339	0.00339	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPY—pancreatic cancer	0.00332	0.00332	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SSTR2—pancreatic cancer	0.00326	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAG2—pancreatic cancer	0.00325	0.00325	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—pancreatic cancer	0.00321	0.00321	CbGpPWpGaD
Tyloxapol—LPL—Disease—MEN1—pancreatic cancer	0.00321	0.00321	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A2—pancreatic cancer	0.00318	0.00318	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCKBR—pancreatic cancer	0.00315	0.00315	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—pancreatic cancer	0.00314	0.00314	CbGpPWpGaD
Tyloxapol—LPL—Disease—SHH—pancreatic cancer	0.00306	0.00306	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NOTCH1—pancreatic cancer	0.00302	0.00302	CbGpPWpGaD
Tyloxapol—LPL—Disease—IAPP—pancreatic cancer	0.00302	0.00302	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DTX4—pancreatic cancer	0.00296	0.00296	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLI1—pancreatic cancer	0.00296	0.00296	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.00292	0.00292	CbGpPWpGaD
Tyloxapol—LPL—Disease—HSPA1B—pancreatic cancer	0.0029	0.0029	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRP1—pancreatic cancer	0.00288	0.00288	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00288	0.00288	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GLP1R—pancreatic cancer	0.00286	0.00286	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—pancreatic cancer	0.00285	0.00285	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—DPYD—pancreatic cancer	0.00281	0.00281	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEY2—pancreatic cancer	0.00277	0.00277	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GAST—pancreatic cancer	0.00271	0.00271	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A2—pancreatic cancer	0.00267	0.00267	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00264	0.00264	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—pancreatic cancer	0.00262	0.00262	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAG1—pancreatic cancer	0.0026	0.0026	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SCT—pancreatic cancer	0.00257	0.00257	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEY1—pancreatic cancer	0.00257	0.00257	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00255	0.00255	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD44—pancreatic cancer	0.00247	0.00247	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCK—pancreatic cancer	0.00245	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Disease—HSPA1A—pancreatic cancer	0.00245	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR2—pancreatic cancer	0.00239	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLP1R—pancreatic cancer	0.00239	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCKAR—pancreatic cancer	0.00235	0.00235	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.00232	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG2—pancreatic cancer	0.00228	0.00228	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MEN1—pancreatic cancer	0.00225	0.00225	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SHH—pancreatic cancer	0.00214	0.00214	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH4—pancreatic cancer	0.00213	0.00213	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IAPP—pancreatic cancer	0.00212	0.00212	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD44—pancreatic cancer	0.00206	0.00206	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTCH1—pancreatic cancer	0.00203	0.00203	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTHLH—pancreatic cancer	0.00203	0.00203	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.00202	0.00202	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNB1—pancreatic cancer	0.00201	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.002	0.002	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCG—pancreatic cancer	0.00198	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—pancreatic cancer	0.00197	0.00197	CbGpPWpGaD
Tyloxapol—LPL—Disease—SMAD4—pancreatic cancer	0.00195	0.00195	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES1—pancreatic cancer	0.0019	0.0019	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STK11—pancreatic cancer	0.00186	0.00186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SST—pancreatic cancer	0.00186	0.00186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG1—pancreatic cancer	0.00182	0.00182	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—pancreatic cancer	0.00181	0.00181	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH3—pancreatic cancer	0.00181	0.00181	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—pancreatic cancer	0.00177	0.00177	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—pancreatic cancer	0.00175	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.00175	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRAS—pancreatic cancer	0.00175	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR1—pancreatic cancer	0.00171	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—pancreatic cancer	0.00167	0.00167	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GCG—pancreatic cancer	0.00166	0.00166	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMS—pancreatic cancer	0.0016	0.0016	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—pancreatic cancer	0.00159	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—pancreatic cancer	0.00159	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Disease—TSC2—pancreatic cancer	0.00159	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR1—pancreatic cancer	0.00158	0.00158	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STK11—pancreatic cancer	0.00156	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—pancreatic cancer	0.00155	0.00155	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—pancreatic cancer	0.00151	0.00151	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—pancreatic cancer	0.0015	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—pancreatic cancer	0.00143	0.00143	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGF—pancreatic cancer	0.00139	0.00139	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMAD4—pancreatic cancer	0.00136	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES1—pancreatic cancer	0.00133	0.00133	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—pancreatic cancer	0.0013	0.0013	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—pancreatic cancer	0.00128	0.00128	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—pancreatic cancer	0.00123	0.00123	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.00123	0.00123	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—pancreatic cancer	0.00118	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—pancreatic cancer	0.00117	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—pancreatic cancer	0.00113	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—pancreatic cancer	0.00113	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—pancreatic cancer	0.00112	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TSC2—pancreatic cancer	0.00111	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—pancreatic cancer	0.00109	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—pancreatic cancer	0.00108	0.00108	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—pancreatic cancer	0.00107	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—pancreatic cancer	0.00107	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—pancreatic cancer	0.00103	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKBIA—pancreatic cancer	0.00101	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—pancreatic cancer	0.001	0.001	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—pancreatic cancer	0.000983	0.000983	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGF—pancreatic cancer	0.000971	0.000971	CbGpPWpGaD
Tyloxapol—LPL—Disease—CTNNB1—pancreatic cancer	0.000953	0.000953	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—pancreatic cancer	0.000929	0.000929	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—pancreatic cancer	0.0009	0.0009	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—pancreatic cancer	0.000892	0.000892	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—pancreatic cancer	0.000864	0.000864	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—pancreatic cancer	0.000862	0.000862	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—pancreatic cancer	0.000831	0.000831	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRAS—pancreatic cancer	0.000829	0.000829	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—pancreatic cancer	0.000778	0.000778	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—pancreatic cancer	0.000772	0.000772	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—pancreatic cancer	0.00077	0.00077	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—pancreatic cancer	0.000755	0.000755	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—pancreatic cancer	0.000753	0.000753	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—pancreatic cancer	0.000724	0.000724	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—pancreatic cancer	0.000713	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—pancreatic cancer	0.000693	0.000693	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—pancreatic cancer	0.000674	0.000674	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNB1—pancreatic cancer	0.000668	0.000668	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—pancreatic cancer	0.000655	0.000655	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—pancreatic cancer	0.000654	0.000654	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—pancreatic cancer	0.000651	0.000651	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—pancreatic cancer	0.000606	0.000606	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—pancreatic cancer	0.000603	0.000603	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—pancreatic cancer	0.000588	0.000588	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—pancreatic cancer	0.000582	0.000582	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRAS—pancreatic cancer	0.00058	0.00058	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—pancreatic cancer	0.000549	0.000549	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—pancreatic cancer	0.000541	0.000541	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—pancreatic cancer	0.000539	0.000539	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—pancreatic cancer	0.000535	0.000535	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—pancreatic cancer	0.000529	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—pancreatic cancer	0.0005	0.0005	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—pancreatic cancer	0.000459	0.000459	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—pancreatic cancer	0.000448	0.000448	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—pancreatic cancer	0.000444	0.000444	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—pancreatic cancer	0.000425	0.000425	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—pancreatic cancer	0.000375	0.000375	CbGpPWpGaD
